Madu Anazoeze Jude, Ughasoro Maduka Donatus
Department of Haematology and Immunology, College of Medicine, University of Nigeria, Enugu, Nigeria.
Med Princ Pract. 2017;26(1):1-9. doi: 10.1159/000452104. Epub 2016 Sep 28.
Anaemia is the most common haematological disorder affecting humanity and is usually observed in chronic disease states such as non-specific anaemia, which may cause diagnostic difficulties. In chronically ill patients with anaemia, this has a negative impact on quality of life as well as survival. This paper aims at reviewing the pathogenesis of this form of anaemia with a view to suggesting future targets for therapeutic intervention. The ability to diagnose this disorder depends on the ability of the physician to correlate the possible clinical pathways of the underlying disease with the patients' ferrokinetic state. It is important to rule out iron deficiency and other causes of anaemia as misdiagnosis will in most cases lead to refractoriness to standard therapy. The cytokines and acute-phase proteins play important roles in the pathogenesis of anaemia of chronic disease. Alterations in the metabolism of iron via the molecule hepcidin and ferritin are largely responsible for the consequent anaemia. Concomitant iron deficiency might be present and could affect the diagnosis and therapeutic protocol. Treatment options involve the use of erythropoiesis-stimulating agents, blood transfusion, and iron supplementation, in addition to treating the underlying disease.
贫血是影响人类的最常见血液系统疾病,通常见于慢性疾病状态,如非特异性贫血,这可能会导致诊断困难。在患有贫血的慢性病患者中,这对生活质量和生存率都有负面影响。本文旨在综述这种贫血形式的发病机制,以期提出未来治疗干预的靶点。诊断这种疾病的能力取决于医生将潜在疾病可能的临床路径与患者铁动力学状态相关联的能力。排除缺铁和其他贫血原因很重要,因为在大多数情况下误诊会导致对标准治疗无效。细胞因子和急性期蛋白在慢性病贫血的发病机制中起重要作用。通过铁调素和铁蛋白分子导致的铁代谢改变在很大程度上是随后贫血的原因。可能存在合并缺铁,这可能会影响诊断和治疗方案。治疗选择包括使用促红细胞生成剂、输血和补充铁剂,此外还要治疗潜在疾病。